Results 61 to 70 of about 17,983,967 (290)
Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose
Malignant rhabdoid tumor of the kidney (MRTK) is a rare, aggressive tumor seen in young children. The optimal timing of resection for locally advanced tumors is not well‐defined. The purpose of this study is to evaluate modern oncologic outcomes and the impact of surgical timing. Methods
A multicenter retrospective review was performed Hannah N. Rinehardt, Elisabeth T. Tracy, Anghela Paredes, Catherine Beckhorn, Harold J. Leraas, Joseph Fusco, Katlyn G. McKay, Nelly‐Ange T. Kontchou, Zachary J. Kastenberg, David W. Hoyt, Jonathan Roach, Emily K. Myers, Nicholas G. Cost, Bhargava Mullapudi, Charles R. Marchese, Amanda R. Jensen, Timothy B. Lautz, Michela Carter, Roshni Dasgupta, John Lundstedt, Joseph G. Brungardt, Lindsay Talbot, Andrew M. Davidoff, Andrew J. Murphy, Jennifer H. Aldrink, Sara Mansfield, Nelson Piche, Annie Le‐Nguyen, Dave R. Lal, Brian T. Craig, Jennifer M. Schuh, Barrett P. Cromeens, Sindhu Mannava, Shannon Castle, Adriana Lopez, Kelsey Mello, Joshua Short, Robin T. Petroze, Shay Rajaval, Grace R. Thompson, Peter Mattei, David H. Rothstein, Elizabeth Fialkowski, Kathryn Fowler, Nathan Martchenke, Barrie S. Rich, Richard D. Glick, Erin G. Brown, Kathleen Doyle, Paige Abril, Natashia Seemann, Jacob Davidson, Claire A. Wilson, Hau D. Le, Devashish Joshi, Michael Stellon, Tamer Ahmed, Alexandra Dimmer, Peter F. Ehrlich, Maya Hammoud, Keyonna Williams, Christa N. Grant, Merit Gorgy, Stephanie F. Polites, Julia Debertin, Danielle B. Cameron, Alyssa Stetson, Eugene S. Kim, William G. Lee, Aaron Barkhordar, Mary Austin, Brian A. Coakley, Anastasia Kahan, Joseph T. Murphy, Michael Pitonak, Chloé Boehmer, Marcus M. Malek +76 morewiley +1 more sourceMYCN Amplification in RB1‐Inactivated Retinoblastoma: Association With High‐Risk Features
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
MYCN amplification occurs in a subset of retinoblastoma cases, both with and without RB1 inactivation. It has been suggested that retinoblastomas with MYCN amplification represent a distinct entity with more aggressive clinical behavior.Kyriaki Papaioannou, Regina Kubica, Karen Fischhuber, Jasmin Beygo, Madlen Reschke, Petra Ritter‐Sovinz, Eva Biewald, Petra Ketteler, Dietmar Lohmann, Deniz Kanber +9 morewiley +1 more sourceSynthesis and crystal structures of 5,5′-(propane-2,2-diyl)bis(2-hydroxybenzaldehyde) and 5,5′-(propane-2,2-diyl)bis(2-hydroxyisophthalaldehyde)
Acta Crystallographica Section E: Crystallographic Communications, 2018 The title compounds 5,5′-(propane-2,2-diyl)bis(2-hydroxybenzaldehyde), C17H16O4, (1), and 5,5′-(propane-2,2-diyl)bis(2-hydroxyisophthalaldehyde), C19H16O6, (2), crystallize with one molecule in the asymmetric unit.Rosario C. Sausa, Dominika N. Lastovickova, John J. La Scala +2 moredoaj +1 more sourcePlanck intermediate results X : Physics of the hot gas in the Coma cluster [PDF]
, 2012 Peer ...1, 10, 10, 14, 38, 25, 2, 3, 34, 37, 38, 4, 47, 42, 42, 44, 48, 48, 48, 48, 49, 5, 53, 55, 55, 6, 63, 65, 67, 67, 67, 67, 67, 67, 84, 69, 7, 73, 1, 74, 74, 74, 77, 79, 79, 8, 8, 8, 8, 8, 8, 8, 82, 83, 87, 87, 87, 87, 29, 88, 9, 9, 92, A. Balbi35, A. Benoˆıt54, A. Bonaldi66, A. Catalano71, A. Chamballu52, A. Da Silva11, A. de Rosa47, A. Gruppuso47, A. J. Banday88, A. Lasenby5, A. Liddle24, A. Melchiorri31, A. Mennella32, A. S. Suur Uski25, A. Zacchei45, A. Zonca28, AMI Collaborations: N. Aghanim55, B. D. Wandelt56, B. P. Crill65, B. Rusholme53, B. Van Tent72, C. Baccigalupi79, C. Burigana47, C. Dickinson66, C. Herna ́ndez Monteagudo12, C. J. MacTavish67, C. R. Lawrence65, C. Renault71, C. Rodr ́ıguez Gonza ́lvez5, C. Rosset1, D. Harrison60, D. Herranz63, D. J. Marshall88, D. L. Clements52, D. Maino32, D. Munshi80, D. Paoletti47, D. Scott22, D. Sutton60, D. Yvon15, E. Battaner90, E. Franceschi47, E. Hivon56, E. Keiha ̈nen25, E. Mart ́ınez Gonza ́lez63, E. Pierpaoli23, E. Pointecouteau88, F. Cuttaia47, F. Feroz5, F. Finelli47, F. K. Hansen61, F. Marleau19, F. Matthai74, F. Noviello66, F. Pajot55, F. Pasian45, F. Perrotta79, F. Piacentini31, F. R. Bouchet56, F. Stivoli50, F. Villa47, G. Chon75, G. de Gasperis35, G. de Zotti43, G. F. Smoot27, G. Hurier71, G. Lagache55, G. Luzzi68, G. Morgante47, G. Patanchon1, G. Polenta4, G. Rocha65, G. Savini78, G. W. Pratt70, GREGORIO, ANNA, H. Bo ̈hringer75, H. Bourdin35, H. Dahle61, H. Dole55, H. K. Eriksen61, H. Kurki Suonio25, I. Bikmaev20, I. Flores Cacho8, I. Khamitov86, I. Ristorcelli88, J. A. Rubin ̃o Mart ́ın62, J. A. Tauber41, J. Aumont55, J. B. Melin15, J. Borrill13, J. De ́mocle`s70, J. Delabrouille1, J. F. Mac ́ıas Pe ́rez71, J. F. Sygnet56, J. Gonza ́lez Nuevo63, J. Knoche74, J. L. Puget55, J. L. Starck70, J. M. Diego63, J. M. Lamarre69, J. P. Bernard8, J. P. Rachen21, J. R. Bond7, K. Benabed56, K. Dolag89, K. Ganga1, K. J. B. Grainge5, K. M. Go ́rski65, K. M. Huffenberger91, L. A. Wade65, L. Cayo ́n26, L. Mendes40, L. Montier88, L. Popa58, L. Terenzi47, L. Toffolatti18, L. Valenziano47, L. Y. Chiang59, M. A. Miville Descheˆnes55, M. Arnaud70, M. Ashdown67, M. Bersanelli32, M. Bucher1, M. Douspis55, M. Frailis45, M. Giard88, M. Hobson5, M. Juvela25, M. Kunz17, M. L. Brown66⋆, M. Le Jeune1, M. Linden Vørnle16, M. Lo ́pez Caniego63, M. Maris45, M. Massardi46, M. Olamaie5, M. P. Schammel5, M. Reinecke74, M. Remazeilles55, M. Rossetti32, M. Tomasi48, M. Tristram68, N. Hurley Walker5, N. Mandolesi47, N. Vittorio35, O. Dore ́65, O. Forni88, O. Perdereau68, P. B. Lilje61, P. Cabella36, P. Carvalho5, P. de Bernardis31, P. Fosalba57, P. Mazzotta35, P. Naselsky76, P. Natoli34, P. Platania64, P. Vielva63, Planck, R. B. Barreiro63, R. Battye66, R. Bhatia6, R. Burenin81, R. C. Butler47, R. D. Davies66, R. D. E. Saunders5, R. J. Davis66, R. Kneissl39, R. Leonardi40, R. R. Chary53, R. Rebolo62, R. Sunyaev74, R. T. Ge ́nova Santos62, S. Colafrancesco44, S. Colombi56, S. Donzelli48, S. Fromenteau1, S. Galeotta45, S. Henrot Versille ́68, S. Leach79, S. Masi31, S. Matarrese30, S. Mitra51, S. Osborne85, S. R. Hildebrandt9, S. Ricciardi47, T. A. Enßlin74, T. J. Pearson9, T. Jagemann40, T. Poutanen42, T. W. Shimwell5, V. Stolyarov5, W. A. Holmes65, X. Dupac40, Y. C. Perrott5, Y. Giraud He ́raud1 +252 morecore +33 more sourcesReciprocal control of viral infection and phosphoinositide dynamics
FEBS Letters, EarlyView.Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.Marie Déborah Bancilhon, Bruno Mesminwiley +1 more source